Internal Medicine, Infectious Disease · Houma, LA
NPI
1003856477
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
1990 Industrial Boulevard
Houma, LA, 70363
Phone (985) 868-9300
Groups this clinician bills Medicare through
Medicare paid, 2024
$30K
526 services
Medicare patients, 2024
163
Average age 69
Drug cost, 2024
$5.0M
14,276 prescriptions
Company payments, 2025
$134
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mary L Eschete was code 99213 (office e&m - established), 206 times for 99 patients. In total Mary L Eschete billed 526 services in 20 codes, and Medicare paid $30K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-10-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Facility | 206 | 99 | $44.54 | $9,176 |
| 99214 Office E&M - Established | Facility | 142 | 82 | $63.22 | $8,977 |
| 99231 Hospital E&M - Subsequent | Facility | 28 | 11 | $35.51 | $994 |
| 99212 Office E&M - Established | Facility | 22 | 15 | $22.77 | $501 |
| 99222 Hospital E&M - Initial | Facility | 17 | 16 | $97.42 | $1,656 |
| 99496 Chronic, Principal, and Transitional Care Management | Facility | 13 | 11 | $133.06 | $1,730 |
| 99203 Office E&M - New | Facility | 12 | 12 | $61.07 | $733 |
By year: 2022 $59K for 985 services; 2023 $46K for 701 services; 2024 $30K for 526 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mary L Eschete prescribed most often to Medicare patients was Gabapentin, with 490 prescriptions and refills. In total Mary L Eschete wrote 14,276 Medicare prescriptions that cost $5.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 490 | 702 | 79 | $5,668 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 379 | 379 | 43 | $9,151 |
| Pravastatin Sodium Generic | 355 | 621 | 62 | $2,706 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 314 | 331 | 57 | $8,171 |
| Atorvastatin Calcium Generic | 308 | 577 | 61 | $1,833 |
| Montelukast Sodium Generic | 294 | 440 | 43 | $1,557 |
| Lisinopril Generic | 294 | 578 | 59 | $1,157 |
| Amlodipine Besylate Generic | 252 | 461 | 50 | $1,023 |
| Juluca Dolutegravir/Rilpivirine | 223 | 223 | 20 | $765K |
| Furosemide Generic | 215 | 404 | 50 | $855 |
| Pantoprazole Sodium Generic | 197 | 268 | 30 | $1,155 |
| Fluticasone Propionate Generic | 192 | 236 | 36 | $2,150 |
| Carvedilol Generic | 192 | 339 | 37 | $1,189 |
| Famotidine Generic | 174 | 258 | 30 | $1,885 |
| Doxycycline Hyclate Generic | 166 | 180 | 59 | $3,759 |
Brand drugs: 2,824 claims; generic drugs: 11,324 claims; opioid claims: 705.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mary L Eschete $134 ($134 in general payments such as food, travel and fees) from 4 companies. The largest payer was Gilead Sciences, Inc. with $78.3.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.